Thursday, 16 August 2018

FDA approves first generic version of Mylan's EpiPen

The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd's generic version of Mylan NV's EpiPen for the emergency treatment of allergic reactions.


No comments:

Post a Comment